file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[1],National Comprehensive Cancer Network. (2021). NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 2.2021.,10.1111/j.1759-7714.2010.00016.x,https://doi.org/10.1111/j.1759-7714.2010.00016.x,"Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009",Xu,2,93
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[2],"Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-fluorouracil: mechanisms of action and clinical strategies. Nature Reviews Cancer, 3(5), 330-338.",10.1038/nrc1074,https://doi.org/10.1038/nrc1074,5-Fluorouracil: mechanisms of action and clinical strategies,Longley,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[3],"Van Cutsem, E., & Cervantes, A. (2011). Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Annals of Oncology, 22(suppl_6), vi61-vi63.",10.1093/annonc/mdq222,https://doi.org/10.1093/annonc/mdq222,Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment,Van Cutsem,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[4],"Le, D. T., et al. (2017). Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science, 357(6349), 409-413.",10.3410/f.727697784.793571316,https://doi.org/10.3410/f.727697784.793571316,Faculty Opinions recommendation of Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.,Berlin,8,83
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[5],"Meacham, C. E., & Morrison, S. J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature, 501(7467), 328-337.",10.1038/nature12624,https://doi.org/10.1038/nature12624,Tumour heterogeneity and cancer cell plasticity,Meacham,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[6],"Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11), 1423-1437.",10.1038/nm.3394,https://doi.org/10.1038/nm.3394,Microenvironmental regulation of tumor progression and metastasis,Quail,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[7],"Franko, J., Shi, Q., & Meyers, J. P. (2012). Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. The Lancet Oncology, 17(12), 1709-1719.",10.1016/s1470-2045(16)30500-9,https://doi.org/10.1016/s1470-2045(16)30500-9,Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database,Franko,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_16,[8],"Jayne, D. G., & Fook, S. (2002). Peritoneal carcinomatosis from colorectal cancer. British Journal of Surgery, 89(12), 1545-1550.",10.1046/j.1365-2168.2002.02274.x,https://doi.org/10.1046/j.1365-2168.2002.02274.x,Peritoneal carcinomatosis from colorectal cancer,Jayne,100,100
